The present work presents translational research with application of AgNPs targeting the global drug resistance problem. In vivo fieldwork was carried out with 400 breeding farm cows sick with a serous mastitis. Ex vivo results revealed that after cow treatment with Lactobay™ (a mixture of antibiotic drugs) the susceptibility to 31 antibiotics of S. aureus isolates from cow breast secretion decreased by 25%, while after treatment with Argovit–C™ silver nanoparticles S. aureus susceptibility increased by 11%. The portion of isolates with an efflux effect leading to elimination of antibiotics from S. aureus after Lactobay-treatment resulted in a 15% increase, while Argovit-C-treat-ment led to a 17.5% decrease. The obtained results showed that mastitis treatments with Argovit-C™ AgNPs can partially restore the activity of antibiotics towards S. aureus and shorten the dura-tion of mastitis treatment by 33%.
CITATION STYLE
Nefedova, E., Shkil, N., Vazquez-Gomez, R. L., Garibo, D., Pestryakov, A., & Bogdanchikova, N. (2022). AgNPs Targeting the Drug Resistance Problem of Staphylococcus aureus: Susceptibility to Antibiotics and Efflux Effect. Pharmaceutics, 14(4). https://doi.org/10.3390/pharmaceutics14040763
Mendeley helps you to discover research relevant for your work.